ProShare Advisors LLC cut its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 2.0% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 862,303 shares of the company’s stock after selling 17,349 shares during the quarter. ProShare Advisors LLC owned approximately 0.10% of Colgate-Palmolive worth $63,923,000 at the end of the most recent reporting period.
Several other institutional investors have also made changes to their positions in the company. First Eagle Investment Management LLC increased its position in shares of Colgate-Palmolive by 2.3% during the 2nd quarter. First Eagle Investment Management LLC now owns 4,891,131 shares of the company’s stock valued at $362,580,000 after purchasing an additional 108,850 shares during the last quarter. TIAA CREF Investment Management LLC increased its position in shares of Colgate-Palmolive by 3.7% during the 2nd quarter. TIAA CREF Investment Management LLC now owns 4,725,042 shares of the company’s stock valued at $350,267,000 after purchasing an additional 170,053 shares during the last quarter. Fiera Capital Corp increased its holdings in Colgate-Palmolive by 17.3% in the 2nd quarter. Fiera Capital Corp now owns 4,595,453 shares of the company’s stock worth $340,662,000 after acquiring an additional 677,657 shares during the last quarter. Legal & General Group Plc increased its holdings in Colgate-Palmolive by 2.2% in the 2nd quarter. Legal & General Group Plc now owns 4,390,317 shares of the company’s stock worth $325,461,000 after acquiring an additional 96,427 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. increased its holdings in Colgate-Palmolive by 1.2% in the 1st quarter. Schwab Charles Investment Management Inc. now owns 3,474,194 shares of the company’s stock worth $254,277,000 after acquiring an additional 39,843 shares during the last quarter. 73.46% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: “Colgate-Palmolive Company (CL) Shares Sold by ProShare Advisors LLC” was first posted by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The correct version of this news story can be viewed at https://www.truebluetribune.com/2017/11/20/colgate-palmolive-company-cl-shares-sold-by-proshare-advisors-llc.html.
In other news, COO Justin Skala sold 126,393 shares of Colgate-Palmolive stock in a transaction dated Thursday, November 9th. The stock was sold at an average price of $72.97, for a total transaction of $9,222,897.21. Following the completion of the sale, the chief operating officer now owns 262,361 shares in the company, valued at approximately $19,144,482.17. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Victoria L. Dolan sold 10,000 shares of Colgate-Palmolive stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $73.07, for a total value of $730,700.00. Following the sale, the insider now owns 60,528 shares of the company’s stock, valued at approximately $4,422,780.96. The disclosure for this sale can be found here. In the last quarter, insiders have sold 173,673 shares of company stock valued at $12,629,293. Corporate insiders own 1.02% of the company’s stock.
Several brokerages recently weighed in on CL. SunTrust Banks, Inc. raised Colgate-Palmolive from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $65.00 to $85.00 in a report on Wednesday, October 11th. Citigroup Inc. decreased their price objective on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a report on Thursday, November 2nd. Stifel Nicolaus set a $73.00 price objective on Colgate-Palmolive and gave the stock a “hold” rating in a report on Sunday, October 29th. Royal Bank Of Canada reissued a “hold” rating and issued a $74.00 price objective on shares of Colgate-Palmolive in a report on Sunday, October 8th. Finally, Zacks Investment Research lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. One analyst has rated the stock with a sell rating, fifteen have issued a hold rating and four have given a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $76.67.
Shares of Colgate-Palmolive Company (NYSE:CL) opened at $71.89 on Monday. The stock has a market capitalization of $63,126.98, a PE ratio of 25.05, a PEG ratio of 3.29 and a beta of 0.80. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42. Colgate-Palmolive Company has a 12-month low of $63.43 and a 12-month high of $77.27.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.73. The firm had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The company’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same quarter last year, the company posted $0.73 EPS. sell-side analysts forecast that Colgate-Palmolive Company will post 2.88 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd were given a dividend of $0.40 per share. The ex-dividend date was Friday, October 20th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.23%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 61.78%.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.